Accelerating Innovation Across Cell Therapies, Viral Vectors, Oligonucleotides and mRNA Delivery Workshop
Presented by Reni Kitte, Research Associate, PhD Candidate, Fraunhofer Institute for Cell Therapy and Immunology IZI (Fraunhofer IZI) Margherita Neri, Vector Process Development Director, AGC Biologics Dr. Barrie Cassey, Technology Lead – MMIC, Dr. Claire MacLeod, Grand Challenge Lead – Oligo Manufacturing at CPI Dr. Maribel Lara Chica, Head of Manufacturing of the Lentiviral Vector Platform for CAR-T Cell Therapy / Postdoctoral Research Scientist at IBiS
The UK’s cell and gene therapy sector is on the threshold of becoming a global leader in the field. While present challenges include the supply of equipment and skills gaps, Innovation Hubs aim to bridge these through collaboration.
Given the widespread incidence of cancers and cardiovascular diseases, having sufficient means to model their behaviour is vital to the development of new treatments. Maintaining tissue contexts in disease modelling is crucial for developing a comprehensive understanding of how different diseases behave.
We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.